Cargando…
Interactions of nebulized heparin with intravenous antithrombin for combined therapy of acute lung injury
Autores principales: | Rehberg, S, Sousse, L, Yamamoto, Y, Traber, LD, Traber, DL, Enkhbaatar, P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066880/ http://dx.doi.org/10.1186/cc9626 |
Ejemplares similares
-
Therapy with recombinant human antithrombin, heparin and tissue plasminogen activator improves survival and reduces ventilation days in a long-term ovine model of cutaneous burn and smoke inhalation injury
por: Asmussen, S, et al.
Publicado: (2011) -
Selective V(1a )agonism reduces vascular leakage and cardiopulmonary dysfunction in methicillin-resistant Staphylococcus aureus sepsis
por: Rehberg, S, et al.
Publicado: (2010) -
Estimating coagulopathy in an ovine acute lung injury model of sepsis using a disease progression model
por: Footer, BW, et al.
Publicado: (2010) -
Increased asymmetrical dimethyl-arginine suppresses nitric oxide production in Pseudomonas aeruginosa sepsis
por: Sousse, L, et al.
Publicado: (2009) -
The selective V(1a )receptor agonist FE 202158 does not cause von Willebrand factor release in sheep unlike arginine vasopressin
por: Rehberg, S, et al.
Publicado: (2009)